Literature DB >> 14571718

PGP9.5 overexpression in esophageal squamous cell carcinoma.

Tsunenobu Takase1, Kenji Hibi, Taiji Yamazaki, Hiroshi Nakayama, Masumi Taguchi, Yasushi Kasai, Katsuki Ito, Seiji Akiyama, Tetsuro Nagasaka, Akimasa Nakao.   

Abstract

BACKGROUND/AIMS: PGP9.5 is a ubiquitin hydrolase widely expressed in neuronal tissue at all stages of neuronal differentiation and has been used as a neuroendocrine marker. Recently, it has been proved that PGP9.5 expression was highly observed in squamous cell carcinoma of lung cancer, suggesting that it might be a tumor marker for squamous cell carcinoma. To better characterize its role in digestive tract cancers, we examined PGP9.5 expression retrospectively in esophageal cancers.
METHODOLOGY: We examined PGP9.5 expression retrospectively in 40 resected esophageal cancers (squamous cell carcinoma) and 10 gastric cancers (adenocarcinoma) using immunohistochemistry.
RESULTS: Of 40 esophageal cancer specimens, 19 (48%) exhibited positive staining with PGP9.5 in most tumor cells, while no PGP9.5 expression was observed in any of the 10 gastric cancers.
CONCLUSIONS: Although the precise mechanism underlying the effect of PGP9.5 on oncogenicity remains to be proven, it was confirmed that it may be a potential marker for esophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571718

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  18 in total

1.  CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.

Authors:  Rania Abdelmaksoud-Dammak; Amena Saadallah-Kallel; Imen Miladi-Abdennadher; Lobna Ayedi; Abdelmajid Khabir; Tahia Sallemi-Boudawara; Mounir Frikha; Jamel Daoud; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2015-08-28

2.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

3.  Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.

Authors:  Huang-Chun Lien; Chung-Chieh Wang; Chiun-Sheng Huang; Ya-Wen Yang; Wen-Hung Kuo; Yu-Tung Yao
Journal:  Virchows Arch       Date:  2013-01-05       Impact factor: 4.064

4.  Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.

Authors:  Tomohiro Kabuta; Takeshi Mitsui; Masaki Takahashi; Yuuki Fujiwara; Chihana Kabuta; Chiho Konya; Yukihiro Tsuchiya; Yusuke Hatanaka; Kenko Uchida; Hirohiko Hohjoh; Keiji Wada
Journal:  J Biol Chem       Date:  2013-03-29       Impact factor: 5.157

5.  The exclusive effects of chaperonin on the behavior of proteins with 52 knot.

Authors:  Yani Zhao; Pawel Dabrowski-Tumanski; Szymon Niewieczerzal; Joanna I Sulkowska
Journal:  PLoS Comput Biol       Date:  2018-03-16       Impact factor: 4.475

6.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

7.  Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.

Authors:  Fatma Trifa; Sondes Karray-Chouayekh; Zeineb Ben Jmaa; Emna Jmal; Abdelmajid Khabir; Tahia Sellami-Boudawara; Mounir Frikha; Jamel Daoud; Raja Mokdad-Gargouri
Journal:  Med Oncol       Date:  2013-01-13       Impact factor: 3.064

8.  The role of PGP9.5 as a tumor suppressor gene in human cancer.

Authors:  Yutaka Tokumaru; Keishi Yamashita; Myoung Sook Kim; Hannah L Park; Motonobu Osada; Masaki Mori; David Sidransky
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

9.  Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.

Authors:  Anjali Bheda; Julia Shackelford; Joseph S Pagano
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.